226 related articles for article (PubMed ID: 33266488)
1. Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P.
Caviglia GP; Rosso C; Armandi A; Gaggini M; Carli F; Abate ML; Olivero A; Ribaldone DG; Saracco GM; Gastaldelli A; Bugianesi E
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266488
[No Abstract] [Full Text] [Related]
2. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
3. SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK/ACC pathway.
Chen Y; He X; Chen X; Li Y; Ke Y
J Cell Physiol; 2021 May; 236(5):3800-3807. PubMed ID: 33094480
[TBL] [Abstract][Full Text] [Related]
4. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.
Gaggini M; Carli F; Rosso C; Buzzigoli E; Marietti M; Della Latta V; Ciociaro D; Abate ML; Gambino R; Cassader M; Bugianesi E; Gastaldelli A
Hepatology; 2018 Jan; 67(1):145-158. PubMed ID: 28802074
[TBL] [Abstract][Full Text] [Related]
5. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.
Köroğlu E; Canbakan B; Atay K; Hatemi İ; Tuncer M; Dobrucalı A; Sonsuz A; Gültepe I; Şentürk H
Turk J Gastroenterol; 2016 Jul; 27(4):361-6. PubMed ID: 27458852
[TBL] [Abstract][Full Text] [Related]
6. Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals.
Xu Y; Ma X; Pan X; He X; Wang Y; Bao Y
Liver Int; 2019 Mar; 39(3):568-574. PubMed ID: 30554468
[TBL] [Abstract][Full Text] [Related]
7. Selenium and selenoprotein P in nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Goulas A; Duntas L
Hormones (Athens); 2020 Mar; 19(1):61-72. PubMed ID: 31493247
[TBL] [Abstract][Full Text] [Related]
8. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
Hossain IA; Rahman Shah MM; Rahman MK; Ali L
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
[TBL] [Abstract][Full Text] [Related]
9. Circulating Concentrations of Insulin Resistance-Associated Hepatokines, Selenoprotein P and Leukocyte Cell-Derived Chemotaxin 2, during an Oral Glucose Tolerance Test in Humans.
Mohri K; Misu H; Takayama H; Ishii KA; Kikuchi A; Lan F; Enyama Y; Takeshita Y; Saito Y; Kaneko S; Takamura T
Biol Pharm Bull; 2019 Mar; 42(3):373-378. PubMed ID: 30606895
[TBL] [Abstract][Full Text] [Related]
10. Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload.
Altamura S; Müdder K; Schlotterer A; Fleming T; Heidenreich E; Qiu R; Hammes HP; Nawroth P; Muckenthaler MU
Mol Metab; 2021 Sep; 51():101235. PubMed ID: 33872860
[TBL] [Abstract][Full Text] [Related]
11. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
[TBL] [Abstract][Full Text] [Related]
12. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.
Luukkonen PK; Zhou Y; Sädevirta S; Leivonen M; Arola J; Orešič M; Hyötyläinen T; Yki-Järvinen H
J Hepatol; 2016 May; 64(5):1167-1175. PubMed ID: 26780287
[TBL] [Abstract][Full Text] [Related]
13. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.
Shipovskaya AA; Dudanova OP; Kurbatova IV
Ter Arkh; 2018 Aug; 90(8):63-68. PubMed ID: 30701940
[TBL] [Abstract][Full Text] [Related]
15. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
[TBL] [Abstract][Full Text] [Related]
16. Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates.
Kamath S; Chavez AO; Gastaldelli A; Casiraghi F; Halff GA; Abrahamian GA; Davalli AM; Bastarrachea RA; Comuzzie AG; Guardado-Mendoza R; Jimenez-Ceja LM; Mattern V; Paez AM; Ricotti A; Tejero ME; Higgins PB; Rodriguez-Sanchez IP; Tripathy D; DeFronzo RA; Dick EJ; Cline GW; Folli F
PLoS One; 2011; 6(11):e27617. PubMed ID: 22125617
[TBL] [Abstract][Full Text] [Related]
17. Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans.
Kratz M; Marcovina S; Nelson JE; Yeh MM; Kowdley KV; Callahan HS; Song X; Di C; Utzschneider KM
Am J Clin Nutr; 2014 Jun; 99(6):1385-96. PubMed ID: 24740208
[TBL] [Abstract][Full Text] [Related]
18. Hepatokines and non-alcoholic fatty liver disease.
Lebensztejn DM; Flisiak-Jackiewicz M; Białokoz-Kalinowska I; Bobrus-Chociej A; Kowalska I
Acta Biochim Pol; 2016; 63(3):459-67. PubMed ID: 27262842
[TBL] [Abstract][Full Text] [Related]
19. Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.
Heebøll S; Poulsen MK; Ornstrup MJ; Kjær TN; Pedersen SB; Nielsen S; Grønbæk H; Handberg A
Int J Obes (Lond); 2017 Feb; 41(2):262-267. PubMed ID: 27916988
[TBL] [Abstract][Full Text] [Related]
20. THE CORRELATION OF NECK CIRCUMFERENCE AND INSULIN RESISTANCE IN NAFLD PATIENTS.
Boemeke L; Raimundo FV; Bopp M; Leonhardt LR; Fernandes SA; Marroni CA
Arq Gastroenterol; 2019; 56(1):28-33. PubMed ID: 31141077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
